World / Cancer

WHO Proposes Strategy For Prevention And Control Of Cancer In The African Region

WHO Proposes Strategy For Prevention And Control Of Cancer In The African Region

Time 04.09.2008 20:17 Source  medicalnewstoday.com

The World Health Organization (WHO) has proposed a strategy to prevent and control cancer, 582 000 cases of which were recorded in the Region in 2002. Cancer of the cervix, breast, liver and prostate as well as Kaposi's sarcoma and non-Hodgkin's lymphoma are the most common forms of cancer in the African Region. Incidence of these cancers are projected to double by 2020 if effective interventions are not intensified.

Region World Category Cancer
Cellvizio(R) Imaging System Improves Bile Duct Cancer Detection According To A New Study In Clinical Gastroenterology And Hepatology

Cellvizio(R) Imaging System Improves Bile Duct Cancer Detection According To A New Study In Clinical Gastroenterology And Hepatology

Time 04.09.2008 14:12 Source  medicalnewstoday.com

A new imaging system that allows physicians to examine tissue at the cellular level from inside the body may now enable them to more effectively diagnose cancer of the bile ducts, according to a new study in the September 2008 issue of the journal Clinical Gastroenterology and Hepatology. This cancer, medically known as cholangiocarcinoma, is one of the most difficult to detect and treat.

Region World Category Cancer
Wall Street Journal Examines Growing Fear Of Breast Cancer Among Some Young Girls

Wall Street Journal Examines Growing Fear Of Breast Cancer Among Some Young Girls

Time 04.09.2008 12:24 Source  medicalnewstoday.com

The Wall Street Journal on Tuesday examined the growing fear of breast cancer among some young girls that in part is because of information about the disease from the media. Marisa Weiss -- director of breast radiation oncology at Lankenau Hospital in Pennsylvania, founder of Breastcancer.

Region World Category Cancer
New Reporting From IntrinsiQ Measures Impact Of Key Events On Oncology Drug Usage

New Reporting From IntrinsiQ Measures Impact Of Key Events On Oncology Drug Usage

Time 04.09.2008 07:02 Source  medicalnewstoday.com

IntrinsiQ, LLC, the expert source for clinical oncology insight, launched Event IntelliView, a new analysis tool that quantifies the real-world impact of key events in the lifecycle of medical oncology drugs. Pharmaceutical research teams can now quickly make sense of vast amounts of product performance data, and see how activities like reporting on clinical findings, regulatory approvals and price changes positively or negatively impact market penetration.

Region World Category Cancer
Clinical Trial Protocol Against Cancer Therapy Side Effects (Mucositis) Approved

Clinical Trial Protocol Against Cancer Therapy Side Effects (Mucositis) Approved

Time 04.09.2008 07:02 Source  medicalnewstoday.com

Anadis Ltd. (ASX:ANX; OTC:ANDIY) an Australian biopharmaceutical company specializing in oral immunotherapy using naturally derived antibodies and other proteins is announcing the clinical protocol for its Cancer-related Mucositis Program was cleared by the Tel Aviv Souraski Medical Center's Institutional Review Board (IRB) and by the Israeli Ministry of Health (MOH). This enables the initiation of the clinical trial addressing this significant target at the medical center within a month.

Region World Category Cancer
Height Linked To Risk Of Prostate Cancer Development And Progression

Height Linked To Risk Of Prostate Cancer Development And Progression

Time 04.09.2008 07:02 Source  medicalnewstoday.com

A man's height is a modest marker for risk of prostate cancer development, but is more strongly linked to progression of the cancer, say British researchers who conducted their own study on the connection and also reviewed 58 published studies. In the September issue of

Region World Category Cancer
Human Genome Sciences Reports Initial Results Of Randomized Phase 2 Trial Of HGS-ETR1 In Combination With Bortezomib In Advanced Multiple Myeloma

Human Genome Sciences Reports Initial Results Of Randomized Phase 2 Trial Of HGS-ETR1 In Combination With Bortezomib In Advanced Multiple Myeloma

Time 04.09.2008 07:02 Source  medicalnewstoday.com

Human Genome Sciences, Inc. (Nasdaq: HGSI) reported initial topline results from an ongoing randomized Phase 2 clinical trial of its TRAIL receptor antibody HGS-ETR1 (mapatumumab) in combination with bortezomib (Velcade) in patients with advanced multiple myeloma. The initial data from the multiple myeloma study show that HGS-ETR1 was well tolerated and suggest that disease response was comparable for this combination vs. bortezomib alone.

Region World Category Cancer
Olivia Newton-John Partners With Curves To Distribute The Liv(R) Breast Self-Exam Aid To 1 Million Women

Olivia Newton-John Partners With Curves To Distribute The Liv(R) Breast Self-Exam Aid To 1 Million Women

Time 04.09.2008 07:02 Source  medicalnewstoday.com

Four-time Grammy winner Olivia Newton-John announces a partnership with Curves, the world's largest fitness franchise for women to launch an international campaign to distribute 1 million units of the Liv® Aid, a breast self-exam aid that assists women to exercise breast self-exams correctly.

Region World Category Cancer
« Previous 0 Next »
« September 2008 »
SunMonTueWedThuFriSat
 010203040506
07080910111213
14151617181920
21222324252627
282930 

Date: 22 November 2008 - 06:31

Number of sources in English: 130